~~<i id='09D251C8D9'><strike id='09D251C8D9'><tt id='09D251C8D9'><pre id='09D251C8D9'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：Wikipedia 2025-09-30 10:24:31 Page View：65

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?
Next article： The cancer drug shortage isn’t new — and neither are the solutions

focus

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

A double vaccine crisis is endangering millions of children

AdobeWorldhealthexpertsmetrecentlytodiscussanemergingglobalhealthcrisislinkedtotheCovid-19pandemic:p

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

'Ancient DNA,' 23andMe reveal African American ancestries

TheIsabellafurnacestackatCatoctinFurnace,nearFrederick,Md.CourtesyCamMillerNewresearchthatcombineste